These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34546112)

  • 1. Surveillance for hepatocellular carcinoma in people of African ancestry with HIV and Hepatitis B.
    Patel N; Post FA
    Int J STD AIDS; 2022 Feb; 33(2):202-204. PubMed ID: 34546112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV.
    Maponga TG; Glashoff RH; Vermeulen H; Robertson B; Burmeister S; Bernon M; Omoshoro-Jones J; Ruff P; Neugut AI; Jacobson JS; Preiser W; Andersson MI
    BMC Gastroenterol; 2020 Jul; 20(1):226. PubMed ID: 32660431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection.
    Surial B; Ramírez Mena A; Roumet M; Limacher A; Smit C; Leleux O; Mocroft A; van der Valk M; Bonnet F; Peters L; Rockstroh JK; Günthard HF; Berzigotti A; Rauch A; Wandeler G; ; ; ;
    J Hepatol; 2023 May; 78(5):947-957. PubMed ID: 36690280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for hepatocellular carcinoma among adults with HIV/HBV co-infection in Zambia: a pilot study.
    Riebensahm C; Chitundu H; Muula G; Chihota B; Sinkala E; Sunkutu V; Maurer MH; Dufour JF; Berzigotti A; Egger M; Bolton-Moore C; Vinikoor M; Wandeler G;
    Int J Infect Dis; 2022 Mar; 116():391-396. PubMed ID: 34952210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of hepatocellular carcinoma in hepatitis B and D virus co-infected patients: A systematic review and meta-analysis of longitudinal studies.
    Kamal H; Fornes R; Simin J; Stål P; Duberg AS; Brusselaers N; Aleman S
    J Viral Hepat; 2021 Oct; 28(10):1431-1442. PubMed ID: 34291520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma risk in sub-Saharan African and Afro-Surinamese individuals with chronic hepatitis B living in Europe.
    Patmore LA; van Eekhout KMA; Buti M; Koc ÖM; Agarwal K; de Knegt RJ; Janssen HLA; van der Valk M; Lieveld FI; Hansen BE; Kramer M; de Bruijne J; Claassen MAA; Smit C; de Man RA; Takkenberg B; Carey I; Sonneveld MJ;
    J Hepatol; 2024 Feb; 80(2):243-250. PubMed ID: 37898348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial.
    Ive P; MacLeod W; Mkumla N; Orrell C; Jentsch U; Wallis CL; Stevens W; Wood R; Sanne I; Bhattacharya D
    PLoS One; 2013; 8(12):e74900. PubMed ID: 24324573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B Virus-related Care Quality in Patients With Hepatitis B/Human Immunodeficiency Virus Coinfection Versus Hepatitis B Monoinfection: A National Cohort Study.
    Lee TH; Hunt CM; Maier MM; Lowy E; Beste LA
    Clin Infect Dis; 2022 Oct; 75(9):1529-1536. PubMed ID: 35349635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moderate levels of serum hepatitis B virus DNA are associated with the highest risk of hepatocellular carcinoma in chronic hepatitis B patients.
    Kim GA; Han S; Choi GH; Choi J; Lim YS
    Aliment Pharmacol Ther; 2020 Jun; 51(11):1169-1179. PubMed ID: 32291781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: the prevention of hepatitis B-related hepatocellular carcinoma.
    Lin CL; Kao JH
    Aliment Pharmacol Ther; 2018 Jul; 48(1):5-14. PubMed ID: 29722445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative performance of risk prediction models for hepatitis B-related hepatocellular carcinoma in the United States.
    Kim HS; Yu X; Kramer J; Thrift AP; Richardson P; Hsu YC; Flores A; El-Serag HB; Kanwal F
    J Hepatol; 2022 Feb; 76(2):294-301. PubMed ID: 34563579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of development of hepatocellular carcinoma in Japanese patients infected with hepatitis B virus is equivalent between genotype B and C in long term.
    Haga H; Saito T; Okumoto K; Tomita K; Katsumi T; Mizuno K; Nishina T; Watanabe H; Ueno Y
    J Viral Hepat; 2019 Jul; 26(7):866-872. PubMed ID: 30924226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma among US and non-US-born patients with chronic hepatitis B: Risk factors and age at diagnosis.
    Kennedy K; Graham SM; Arora N; Shuhart MC; Kim HN
    PLoS One; 2018; 13(9):e0204031. PubMed ID: 30252863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What can we learn from hepatitis B virus clinical cohorts?
    Lin CL; Tseng TC; Kao JH
    Liver Int; 2015 Jan; 35 Suppl 1():91-9. PubMed ID: 25529093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Occult hepatitis B virus infection and hepatocellular carcinoma].
    Lee JJ; Kwon OS
    Korean J Gastroenterol; 2013 Sep; 62(3):160-4. PubMed ID: 24077626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
    Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
    Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A population-based cohort study for the risk factors of HCC among hepatitis B virus mono-infected subjects in Japan.
    Kusakabe A; Tanaka Y; Inoue M; Kurbanov F; Tatematsu K; Nojiri S; Joh T; Tsugane S; Mizokami M
    J Gastroenterol; 2011 Jan; 46(1):117-24. PubMed ID: 20820820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma screening in a hepatitis B virus-infected Korean population.
    Park SH; Heo NY; Park JH; Kim TO; Yang SY; Kim HK; Moon YS; Kim CH; Suk KT; Kim DJ; Lee HY
    Dig Dis Sci; 2012 Dec; 57(12):3258-64. PubMed ID: 22729598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma surveillance rates in commercially insured patients with noncirrhotic chronic hepatitis B.
    Goldberg DS; Valderrama A; Kamalakar R; Sansgiry SS; Babajanyan S; Lewis JD
    J Viral Hepat; 2015 Sep; 22(9):727-36. PubMed ID: 25581816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Level of Hepatitis B Core-Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load.
    Tseng TC; Liu CJ; Hsu CY; Hong CM; Su TH; Yang WT; Chen CL; Yang HC; Huang YT; Fang-Tzu Kuo S; Liu CH; Chen PJ; Chen DS; Kao JH
    Gastroenterology; 2019 Dec; 157(6):1518-1529.e3. PubMed ID: 31470004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.